Document is current
Any future updates will be listed below
-
Authors
Yu, Bingfei https://orcid.org/0000-0001-5550-6701
Chang, Howard Y. https://orcid.org/0000-0002-9459-4393
-
Funding
Funding for this research was provided by:
Stanford RNA Medicine Program Scleroderma Research Foundation
Scleroderma Research Foundation
- License Information
-
More Information
Article History
Received: 2 August 2025
Accepted: 20 October 2025
First Online: 2 January 2026
Competing interests
: H.Y.C. is a cofounder of Accent Therapeutics, Boundless Bio, Cartography Biosciences and Orbital Therapeutics, and was an advisor of 10x Genomics, Arsenal Bio, Chroma Medicine, Exai Bio and Vida Ventures. H.Y.C. is an employee and stockholder of Amgen as of 16 December 2024. B.Y. has no competing interests.
